Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy

The Lancet

Volumn 346, Issue 8989, 1995, Pages 1528-1530

  Eschwège, P ^a   Blanchet, P ^a   Benoit, G ^a   Jardin, A ^a   Dumas, F ^b   Le Maire, V ^b   Lacour, B ^b   Loric, S ^b  

^a BICÊTRE HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER CELL; CLINICAL ARTICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATE SURGERY; PROSTATECTOMY;

EID: 0028834768     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)92054-4     Document Type: Article

References (9)

1. Radical prostatectomy for clinical stage T1-2, N-0, M-0 prostatic adenocarcinoma: long-term results
2. Outcome for lymph node dissection negative T-1b, T-2(A-2B) prostate cancer treated with external beam radiation therapy in RTOG 77-06
3. The role of vertebral veins in the dissemination of prostatic carcinoma
4. Detection of hematogenous micrometastasis in patients with prostate cancer
5. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay
6. Possible mechanisms for seeding of tumor during radical prostatectomy
7. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen based assays
8. How and when do tumor cells metastatize